Related Experiment Video
Updated: Mar 8, 2026

10:30
Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
19.3K
[Juvenile-onset muscular diseases]
Petra Aden1, Ellen J Annexstad2, Espen Lien3
1Seksjon for nevrohabilitering Oslo universitetssykehus.
Summary
Paediatric neurology addresses serious childhood muscular diseases. Promising advancements offer hope for causal treatments for some of these challenging conditions.
Area of Science:
- Paediatric Neurology
- Muscular Diseases
- Childhood Neuromuscular Disorders
Background:
- Children with muscular diseases represent a significant patient group within paediatric neurology.
- These conditions often present severe challenges, necessitating comprehensive interdisciplinary care and support.
- The management of paediatric neuromuscular disorders requires a multidisciplinary approach.
Purpose of the Study:
- To highlight the importance of paediatric neurology in managing childhood muscular diseases.
- To underscore the complexity and severity of certain neuromuscular conditions in children.
- To convey emerging optimism for targeted therapeutic interventions.
Main Methods:
- Review of current paediatric neurology practices for muscular diseases.
- Analysis of treatment challenges and interdisciplinary care models.
- Assessment of recent developments in causal treatment research for paediatric neuromuscular disorders.
Main Results:
- Childhood muscular diseases are a critical area within paediatric neurology.
- Effective management requires extensive interdisciplinary collaboration and facilitation.
- Research shows potential for causal treatments in specific conditions.
Conclusions:
- Paediatric muscular diseases demand specialized neurological care.
- Interdisciplinary treatment is essential for managing severe cases.
- Advancements in research offer optimism for future causal therapies.
Related Concept Videos
Disorders of the Skeletal Muscle
2.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.1K
Satellite Stem Cells and Muscular Dystrophy
2.5K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.5K
Myasthenia Gravis: Diagnostic Tests
2.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K
Myasthenia Gravis: Overview and Treatment
3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K
Chemical Synapses
12.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.2K
Chemical Synapses
6.0K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
6.0K

